Compare Stocks → Get out of dollars—get into America’s new money instead (From Stansberry Research) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDigital Media StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NASDAQ:DOCS Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDOCSDoximity$27.73-0.1%$25.68$19.71▼$36.29$5.17B1.181.80 million shs1.53 million shs5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDOCSDoximity-2.58%+1.35%+14.37%-0.96%-9.42%Get out of dollars—get into America’s new money instead (Ad)Is America's New Money right for you? I can't say... but I do know it's 100% legal and available to everyone... although precious few know much about it.Everything you need to know is posted on our website here.MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationDOCSDoximity2.5591 of 5 stars2.10.00.00.02.54.22.5Analyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDOCSDoximity2.13Hold$28.733.60% UpsideCurrent Analyst RatingsLatest DOCS, NFC, CURY, and WOSG Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/17/2024DOCSDoximityWilliam BlairSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform5/17/2024DOCSDoximityEvercore ISISubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetIn-Line ➝ In-Line$28.00 ➝ $29.005/17/2024DOCSDoximityNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingHold4/25/2024DOCSDoximityJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeUnderweight ➝ Neutral$25.004/23/2024DOCSDoximityMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingUnderweight ➝ Underweight$25.00 ➝ $25.004/2/2024DOCSDoximityEvercore ISISubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingIn-Line ➝ In-Line$30.003/15/2024DOCSDoximityJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetUnderweight ➝ Underweight$22.00 ➝ $25.00(Data available from 5/31/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDOCSDoximity$475.42M10.88$0.90 per share30.92$4.83 per share5.74Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDOCSDoximity$147.58M$0.7238.5134.235.3831.04%17.44%14.85%8/13/2024 (Estimated)DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthDOCSDoximityN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioDOCSDoximityN/A6.206.20OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDOCSDoximity87.19%Insider OwnershipCompanyInsider OwnershipDOCSDoximity39.40%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableDOCSDoximity977186.55 million113.05 millionNot OptionableDOCS, NFC, CURY, and WOSG HeadlinesRecent News About These CompaniesMay 31 at 6:31 PM | prnewswire.comClass Action Announcement for Doximity, Inc. (DOCS): Kessler Topaz Meltzer & Check, LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Doximity, Inc.May 31 at 11:00 AM | accesswire.comDEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in Doximity, Inc. with Losses to Contact the FirmMay 31 at 10:35 AM | prnewswire.comDEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of DoximityMay 31 at 5:00 AM | accesswire.comIMMINENT DOCS DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Doximity, Inc. Investors to Join the Class Action Lawsuit!May 31 at 4:56 AM | marketbeat.com1,283,719 Shares in Doximity, Inc. (NASDAQ:DOCS) Bought by Norges BankMay 30 at 10:30 PM | accesswire.comDOXIMITY SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Doximity, Inc. - DOCSMay 30 at 4:56 PM | prnewswire.comROSEN, A LONGSTANDING LAW FIRM, Encourages Doximity, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - DOCSMay 30 at 4:01 PM | businesswire.comDoximity to Present at the William Blair 44th Annual Growth Stock ConferenceMay 30 at 4:00 PM | prnewswire.comDOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud LawsuitMay 30 at 2:31 PM | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Doximity, Inc. - DOCSMay 30 at 12:30 PM | accesswire.comNYSE: DOCS: Kessler Topaz Meltzer & Check, LLP Files a Securities Class Action Lawsuit Against Doximity, Inc.May 29 at 1:01 PM | zacks.comDoximity (DOCS) Upgraded to Buy: Here's What You Should KnowMay 28 at 10:48 PM | markets.businessinsider.comIMPORTANT SHAREHOLDER NOTICE: The Schall Law Firm Encourages Investors in Doximity, Inc. with Losses to Contact the FirmMay 28 at 4:02 PM | marketbeat.comDoximity is the Facebook and LinkedIn of the Medical CommunityMay 28 at 12:47 PM | bakersfield.comSHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Doximity,May 27, 2024 | marketbeat.comEdmond DE Rothschild Holding S.A. Has $64.56 Million Position in Doximity, Inc. (NASDAQ:DOCS)May 27, 2024 | businesswire.comNYSE: DOCS: Kessler Topaz Meltzer & Check, LLP Announces the Filing of a Securities Class Action Lawsuit Against Doximity, Inc.May 26, 2024 | finance.yahoo.comDoximity Full Year 2024 Earnings: EPS Beats ExpectationsMay 26, 2024 | marketbeat.comPrincipal Financial Group Inc. Cuts Holdings in Doximity, Inc. (NASDAQ:DOCS)May 25, 2024 | markets.businessinsider.comDEADLINE ACTION ALERT: The Schall Law Firm Encourages Investors in Doximity, Inc. with Losses to Contact the FirmMay 25, 2024 | marketbeat.comTrexquant Investment LP Buys 37,069 Shares of Doximity, Inc. (NASDAQ:DOCS)New MarketBeat Followers Over TimeMedia Sentiment Over TimeTop Headlines3 Value Stocks You Can Buy Before They Become BigMay 6, 2024 8:00 AMView 3 Value Stocks You Can Buy Before They Become Big3 Stocks Nancy Pelosi Has Been BuyingMay 10, 2024 8:35 AMView 3 Stocks Nancy Pelosi Has Been Buying3 Affordable Stocks That Won’t Stay Down Much LongerMay 13, 2024 9:12 AMView 3 Affordable Stocks That Won’t Stay Down Much Longer3 Reasons Nvidia is on The Verge of a 4 Digit Stock PriceMay 17, 2024 8:39 AMView 3 Reasons Nvidia is on The Verge of a 4 Digit Stock PriceDoximity is the Facebook and LinkedIn of the Medical CommunityMay 22, 2024 6:05 AMView Doximity is the Facebook and LinkedIn of the Medical CommunityAll HeadlinesCompany DescriptionsDoximityNASDAQ:DOCSDoximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical manufacturers and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
